Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
2.
Sociol Health Illn ; 40(5): 892-906, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29664118

RESUMEN

It is well documented that emergency service staff consider some patients to be 'inappropriate attenders'. A central example is 'trivia', denoting patients with medical problems considered too 'trivial' to warrant attention. Although research has repeatedly shown that frontline staff violate guidelines in turning away 'trivial' patients, existing research has paid insufficient attention to why staff are willing to engage in guideline-violating gatekeeping, which may put both themselves and 'trivial' patients at risk. To address this issue, the present article explores nurses' narratives about 'trivial' patients - referred to in this context as 'GP patients' - drawing on fieldwork data from a Norwegian emergency service. The article reconstructs three narrative clusters, showing that nurses' gatekeeping is motivated by concerns for the patient being turned away, for nurses and more critically ill patients, and for the service they work for. Some of the issues embedded in these narratives have been under-analysed in previous research - most importantly, the role of identity and emotion in nurses' gatekeeping, and how patient narratives can function as 'social prognoses' in nurses' assessments. Analysis of these narratives also reveals an antagonistic relationship between nurses and 'trivial' patients that contradicts nurses' ethical guidelines and indicates a need for healthcare reform.


Asunto(s)
Control de Acceso/ética , Narración , Enfermeras y Enfermeros , Triaje , Adulto , Actitud del Personal de Salud , Servicio de Urgencia en Hospital , Femenino , Control de Acceso/legislación & jurisprudencia , Asignación de Recursos para la Atención de Salud/ética , Humanos , Noruega , Índice de Severidad de la Enfermedad , Triaje/ética , Triaje/normas
3.
Manag Care ; 27(4): 14-16, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29701580

RESUMEN

The CNN story once again puts controversy about prior authorization into the spotlight. But is it necessary to review a patient's entire medical record?


Asunto(s)
Control de Acceso/legislación & jurisprudencia , Cobertura del Seguro , Seguro de Salud , California , Gobierno Estatal
4.
Medicine (Baltimore) ; 96(38): e7719, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28930820

RESUMEN

To assess the effects of the gatekeeper policy implemented in Shenzhen, China, in conjunction with a labor health insurance program, on channeling patients toward community health centers (CHCs).Eight thousand patients who visited 8 CHCs in Shenzhen were surveyed between May 1, 2013 and July 28, 2013. Half of the patients were subject to gatekeeper policy and the other half of them were not. Structured questionnaire was used to collect patients' choices of initial medical institution, use of CHCs and their satisfaction with health care. Bivariate and regression analyses were used to compare patient's choice, utilization, and satisfaction of CHCs.Compared with patients who were free to seek medical care at any place, patients with gatekeepers were 1.77 (95% CI 1.37-2.30) times more likely to choose CHCs first when seeking care. In the past year, the group with gatekeeper made 0.88 more visits to CHCs in the past year than the group without gatekeeper (P < .01), controlling for influencing factors. The 2 groups were equally satisfied with all satisfaction measures except for "waiting time," which was higher among patients without gatekeepers (P < .01).Our study indicates that, as repeatedly proven in other parts of the world, gatekeeping is effective in orienting patients toward primary care system. Along with increased efforts in rebuilding China's primary care network and expanding health insurance coverage, implementation of gatekeeper policy may help increase access to care, reduce inappropriate use of health resources, and strengthen primary care institutions.


Asunto(s)
Centros Comunitarios de Salud/estadística & datos numéricos , Servicios de Salud Comunitaria/estadística & datos numéricos , Control de Acceso/estadística & datos numéricos , Aceptación de la Atención de Salud/estadística & datos numéricos , Adolescente , Adulto , China , Servicios de Salud Comunitaria/legislación & jurisprudencia , Estudios Transversales , Femenino , Control de Acceso/legislación & jurisprudencia , Humanos , Masculino , Satisfacción del Paciente , Encuestas y Cuestionarios , Factores de Tiempo , Adulto Joven
6.
Am J Ind Med ; 59(12): 1070-1086, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27699820

RESUMEN

BACKGROUND: This study sought to identify impacts of compensation system characteristics on doctors in Québec and Ontario. METHODS: (i) Legal analysis; (ii) Qualitative methods applied to documentation and individual and group interviews with doctors (34) and other system participants (31); and (iii) Inter-jurisdictional transdisciplinary analysis involving cross-disciplinary comparative and integrative analysis of policy contexts, qualitative data, and the relationship between the two. RESULTS: In both jurisdictions the compensation board controlled decisions on work-relatedness and doctors perceived the bureaucratic process negatively. Gatekeeping roles differed between jurisdictions both in initial adjudication and in dispute processes. Québec legislation gives greater weight to the opinion of the treating physician. These differences affected doctors' experiences. CONCLUSIONS: Policy-makers should contextualize the sources of the "evidence" they rely on from intervention research because findings may reflect a system rather than an intervention effect. Researchers should consider policy contexts to both adequately design a study and interpret their results. Am. J. Ind. Med. 59:1070-1086, 2016. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Rol del Médico , Indemnización para Trabajadores/legislación & jurisprudencia , Control de Acceso/legislación & jurisprudencia , Humanos , Ontario , Políticas , Investigación Cualitativa , Quebec
9.
J Aging Stud ; 34: 29-37, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26162723

RESUMEN

According to Taiwanese government policies and regulations, families planning to hire migrant care workers must apply for a medical assessment of the needs of elderly people destined to be cared for. The physician conducting this assessment acts as a gatekeeper who carries out her/his work with state and medical profession authority to identify, define, and regulate older people's needs. Using institutional ethnography as the method of inquiry, this article locates the problematic nature of the medical assessment as an entry point to an inquiry into how the care needs met by migrant workers are textually-mediated. This article begins by telling the daily story of an old woman and her live-in migrant worker to point out the standpoint of care recipients and their families where the inquiry anchors. I examine the physicians' daily working activities of medical assessment to discover how policy subordinates people's interests to the governmental purpose.


Asunto(s)
Cuidadores/provisión & distribución , Evaluación de Necesidades/normas , Pautas de la Práctica en Medicina/normas , Profesionalismo/normas , Migrantes/legislación & jurisprudencia , Anciano , Cuidadores/legislación & jurisprudencia , Evaluación de la Discapacidad , Empleo/legislación & jurisprudencia , Femenino , Control de Acceso/legislación & jurisprudencia , Control de Acceso/normas , Evaluación Geriátrica , Regulación Gubernamental , Política de Salud , Humanos , Masculino , Pautas de la Práctica en Medicina/legislación & jurisprudencia , Profesionalismo/legislación & jurisprudencia , Taiwán
11.
Soc Sci Med ; 131: 255-62, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25661300

RESUMEN

By 2004 the FDA had emerged as a champion of pharmacogenomics as an exemplar for novel approaches to drug development. This was made clear in 2004 when the agency released a wide-ranging report which positioned pharmacogenomics at the heart of a broader regulatory reform agenda. The Critical Path initiative addressed declining productivity of drug development by suggesting that the problem was a mismatch between the rapid pace of discovery in post-genomic biomedicine and the antiquated development process for new drugs. Framing their work in this context, FDA officials reconceptualised their role in the innovation process, in what was the first programmatic statement of a shift from a strictly gate-keeping role to a more collaborative or facilitative role as enablers of innovation. This paper situates the FDA's emergence as a champion of pharmacogenomics in the broader politics of pharmaceutical regulation in the USA. In making a contribution to the pharmaceuticalisation literature this paper will draw on the work of John Abraham who has argued that one of the primary drivers of pharmaceuticalisation has been "deregulatory state policies" and on Williams and colleagues who have argued that the changing relationship between regulatory agencies and the pharmaceutical industry is an important dimension of pharmaceuticalisation. This paper links this to the promotion of pharmaceutical futures such as pharmacogenomics and explores how this shift is also closely related to the trend towards a risk management approach to pharmaceutical regulation. The role of Bush appointees in the development and promotion of the Critical Path agenda is also examined.


Asunto(s)
Descubrimiento de Drogas , Drogas en Investigación , Invenciones , Farmacogenética , Política , United States Food and Drug Administration , Descubrimiento de Drogas/legislación & jurisprudencia , Industria Farmacéutica/legislación & jurisprudencia , Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Control de Acceso/legislación & jurisprudencia , Invenciones/legislación & jurisprudencia , Medicina de Precisión , Estados Unidos , United States Food and Drug Administration/legislación & jurisprudencia
16.
Br J Community Nurs ; 12(7): 317-21, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17851312

RESUMEN

In recent months there has been renewed public and parliamentary debate on whether the abortion law in the United Kingdom should be reformed. Parliament has debated the issue on three occasions and now the House of Commons Select Committee on Science and Technology are calling for evidence in support of their inquiry into reform of the Abortion Act 1967. The inquiry gives district nurses the opportunity to inform the debate and ensure that their voices are heard given that topics for reform include nurse-led abortions and home abortions. In this article Richard Griffith and Cassam Tengnah review the development of the law relating to abortion and highlight the areas of reform to be considered by the select committee.


Asunto(s)
Aborto Legal , Aborto Terapéutico/legislación & jurisprudencia , Aborto Legal/efectos adversos , Aborto Legal/métodos , Aborto Legal/enfermería , Aborto Legal/tendencias , Aborto Terapéutico/efectos adversos , Aborto Terapéutico/métodos , Aborto Terapéutico/enfermería , Anticonceptivos Poscoito , Femenino , Control de Acceso/legislación & jurisprudencia , Edad Gestacional , Humanos , Consentimiento Informado/legislación & jurisprudencia , Selección de Paciente , Rol del Médico , Embarazo , Enfermería en Salud Pública/organización & administración , Factores de Riesgo , Reino Unido , Derechos de la Mujer/legislación & jurisprudencia
20.
Manag Care Interface ; 17(4): 37-40, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15108759

RESUMEN

Beginning in the 1990s, with increased attention focused on the alleged abuses and arbitrary decision making by MCOs, several states began enacting legislation to establish health care ombudsmen. A variety of states, including the District of Columbia, are now considering health care ombudsman legislation. This article focuses on the varying role, functions, and duties of the health care ombudsman in each of these states and their benefit to the health care environment.


Asunto(s)
Atención a la Salud , Defensa del Paciente , Rol Profesional , Toma de Decisiones , Control de Acceso/legislación & jurisprudencia , Programas Controlados de Atención en Salud/legislación & jurisprudencia , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA